Prospective Analysis of Robot-Assisted Surgery

Sponsor
Instituto do Cancer do Estado de São Paulo (Other)
Overall Status
Unknown status
CT.gov ID
NCT02292914
Collaborator
(none)
1,120
1
2
76
14.7

Study Details

Study Description

Brief Summary

The robot-assisted surgery allows three-dimensional view, detailed access of small structures, depth perception and articulated movements with wide latitude. Thinking about the inclusion of this branch of surgical outcome ICESP encouraged the training of their doctors and other health professionals , and has three tutors in the area of robot- assisted laparoscopic surgery , and various medical clinical staff , already trained , and already perform the procedure in other centers . The da Vinci ® Surgical System ( only existing in the World market) , consisting of one or two consoles for the surgeon and a tutor if necessary was adopted. Ergonomically designed, a stand next to the patient , with four interactive robotic arms , one of them , a vision system for high performance and the other three for exclusive EndoWrist ® instruments . Driven by the latest robotic technology , computer programs , frictionless transmission of manual controls , movements in scale and filtered made by the surgeon in the da Vinci ® System console are translated into precise movements of the instruments EndoWrist ® For surgeons , the da Vinci ® System offers superior 3D viewing with larger surgical precision ergonomic comfort and dexterity . For hospitals , the da Vinci ® Surgical System enables clinical and economic benefits of minimally invasive surgery are applied to a broader base of patients cirúrgicos.The main objective is to evaluate the safety and effectiveness of robotic surgery in the surgical treatment of cancer in operations below, as their specialties : Digestive , Urology , Gynecology , Head and Neck and Thorax . This is a prospective study lasting 36 months , where 1120 patients with surgical diseases in programming for the following operations will be studied : transthoracic esophagectomy ; subtotal gastrectomy with lymphadenectomy ; partial pancreatectomy ; resection of the rectum ; prostatectomy ; cystectomy ; partial nephrectomy ; hysterectomy with or without pelvic and paraaortic lymphadenectomy ; resection of malignant tumors of the mouth and orofaringolaringe and lung lobectomy . Patients will come from the outpatient services of the Institute of Cancer of São Paulo - ICESP

Condition or Disease Intervention/Treatment Phase
  • Procedure: Robot-assisted surgery
  • Procedure: Conventional Surgery
N/A

Detailed Description

This is a prospective study lasting 36 months. This project includes 10 subprojects in five different specialties:

Specialty: Surgery of the Digestive System Subproject 1: trans-thoracic esophagectomy Subproject 2: subtotal gastrectomy with lymphadenectomy Subproject 3: partial pancreatectomy Subproject 4: resection of the rectum Specialty: Urology Surgery Subproject 5: cystectomy Subproject 6: Prostatectomy Subproject 7: Partial Nephrectomy Specialty: Gynecological Surgery Activity 8: Hysterectomy with or without pelvic lymphadenectomy and paraaortic Specialty: Head and Neck Surgery Activity 9: resection of malignant tumors of the mouth and orofaringolaringe Specialty: Thoracic Surgery Subproject 10: pulmonary lobectomies

Each subproject will have a study design, inclusion criteria, exclusion criteria and specific methodologies.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Prospective Analysis of Robot-Assisted Surgery
Study Start Date :
Mar 10, 2014
Anticipated Primary Completion Date :
Jul 10, 2020
Anticipated Study Completion Date :
Jul 10, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Robot-Assisted Surgery

patients undergoing robot assisted surgery for the treatment of cancer

Procedure: Robot-assisted surgery
Robot-assisted esophagectomy; Robot-assisted subtotal gastrectomy; Robot-assisted pancreatectomy;Robot-assisted rectal resection; Robot-assisted radical cistectomy;Robot-assisted prostatectomy;Robot-assisted Partial Nephrectomy; Robot-assisted hysterectomy;Robot-assisted Resection of malignant tumors of the mouth and orofaringolaringe; Robot-assisted lung lobectomy

Active Comparator: Conventional Surgery

patients undergoing conventional surgery for the treatment of cancer

Procedure: Conventional Surgery
Thoracoscopic Esophagectomy; Open rectal resection and rectal laparoscopy resection; Open radical cistectomy; Open prostatectomy; Open Partial Nephrectomy; Laparoscopic hysterectomy; Laparoscopic lung lobectomy

Outcome Measures

Primary Outcome Measures

  1. Postoperative Complications [30 days]

    The postoperative complications will be mesured by clavien-dindo scale

Secondary Outcome Measures

  1. ICU and hospital length of stay [2 days]

Other Outcome Measures

  1. Surgical time [1 day]

  2. Intraoperative complications [1 day]

    The intraoperative complications will be mesured by clavien-dindo scale

  3. quality of life of cancer patients [36 months]

    The quality of life will be measured by the EORTC QLQ-C30 questionnaire, developed to assess the quality of life of cancer patients

  4. overall survival [5 years]

  5. Disease free survival [5 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients eligible for robotic-assisted surgery
Exclusion Criteria:
  • Pregnant patients

  • Patients with decompensated systemic diseases

  • Patients who were unfit for general anesthesia

  • Patients without an indication for surgical treatment of cancer

Contacts and Locations

Locations

Site City State Country Postal Code
1 Instituto do Câncer de São Paulo - ICESP São Paulo Brazil

Sponsors and Collaborators

  • Instituto do Cancer do Estado de São Paulo

Investigators

  • Principal Investigator: Ivan Cecconello, MD, Faculdade de Medicina da USP
  • Principal Investigator: Ulysses Ribeiro-Junior, MD, Faculdade de Medicina da USP

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Instituto do Cancer do Estado de São Paulo
ClinicalTrials.gov Identifier:
NCT02292914
Other Study ID Numbers:
  • NP433/13
First Posted:
Nov 18, 2014
Last Update Posted:
Aug 8, 2019
Last Verified:
Aug 1, 2019
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2019